Why are you looking at Abbott Rapid Dx North America?
Capability
Service linesIN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING · PHARMACEUTICAL PREPARATION MANUFACTURING · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Work mix: 100% prime · 0% sub · primary NAICS 423450 / PSC 6640 LABORATORY EQUIPMENT AND SUPPLIES
Where they win
2 agenciesRecompete exposure: None
No incumbent recompetes detected in the next 24 months.
Agency buyer map
2 buyersRecompete exposure
NoneNo incumbent recompetes detected in the next 24 months.
No incumbent recompetes detected in the next 24 months.
GET THE FULL BRIEF
Get Abbott Rapid Dx North America’s recompete exposure, top agencies and teaming history
The outlook above is free to read and verify — an estimated $42.8M in play. Enter a work email for two figures the page cannot show.
“With competitive federal procurements, winning starts with strategically understanding the customer environment to the left of SAM.gov. This is what SCOUT does - a deeper and more precise understanding of what the…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Abbott Rapid Dx North America hold?
Abbott Rapid Dx North America (UEI P782RNU1NNK3) shows $42.8M across 9132 award actions in SCOUT’s public USASpending-backed profile, with Department of Defense (DOD) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
Which agencies does Abbott Rapid Dx North America work with?
Abbott Rapid Dx North America’s firm-wide obligated mix is led by Department of Defense (DOD) (10%), Department of State (DOS) (1%).
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →